Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents’ efficacy
George Papacharalampous, Jannis Constantinidis, G. Fotiadis, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 1, pp. 96-109
Open Access | Times Cited: 21

Showing 21 citing articles:

Mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience
Cosimo Galletti, Federico Sireci, Giovanna Stilo, et al.
American Journal of Otolaryngology (2025) Vol. 46, Iss. 1, pp. 104597-104597
Open Access | Times Cited: 2
Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives
Ewa Alska, Dariusz Łaszczych, Katarzyna Napiórkowska-Baran, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1079-1079
Open Access | Times Cited: 1
Effectiveness and safety profile of mepolizumab in chronic rhinosinusitis with nasal polyps: Real life data in a tertiary care
Cosimo Galletti, Francesco Ciodaro, María Antonietta Barbieri, et al.
American Journal of Otolaryngology (2024) Vol. 45, Iss. 4, pp. 104329-104329
Closed Access | Times Cited: 6
Recent Treatment Trends of Chronic Rhinosinusitis (CRS): According to Phenotype and Endotype
Joon Kon Kim
IntechOpen eBooks (2025)
Closed Access
Switching biologics in chronic rhinosinusitis with nasal polyps: A multicenter Canadian experience
Marisa Dorling, Masih Sarafan, Béatrice Voizard, et al.
International Forum of Allergy & Rhinology (2024) Vol. 15, Iss. 2, pp. 166-173
Open Access | Times Cited: 3
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
Angélica Tiotiu, Nicolas Migueres, Francisco Javier González‐Barcala, et al.
Respiratory Medicine (2025) Vol. 238, pp. 107979-107979
Closed Access
Results of personalized biological therapy in patients with chronic rhinosinusitis with nasal polyps and severe uncontrolled bronchial asthma – real-life study
Edyta Jura-Szołtys, Aleksandra Niemiec, Joanna Glück, et al.
Otolaryngologia Polska (2025) Vol. 79, Iss. 2, pp. 1-6
Closed Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review
Sara Munari, Giulia Ciotti, Walter Cestaro, et al.
Drugs in Context (2024) Vol. 13, pp. 1-11
Open Access | Times Cited: 3
Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis
Huikang Wang, Xinjun Xu, Zhaoyang Lu, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 282, Iss. 2, pp. 559-569
Closed Access | Times Cited: 2
Current Review of Comorbidities in Chronic Rhinosinusitis
Alexander Choi, Shuhui Xu, Amber Luong, et al.
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access | Times Cited: 2
Impact of Biologics on Surgery in Chronic Rhinosinusitis with Polyps and Allergic Fungal Sinusitis
Mihai A. Bentan, Graham Pingree, Lawrance Lee, et al.
The Laryngoscope (2024) Vol. 135, Iss. 2, pp. 593-601
Open Access | Times Cited: 1
Assessing the predictive potential of ADAM8 for disease control in chronic rhinosinusitis with nasal polyps
Peiqiang Liu, Meng Liu, Yibin Sun, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 1
Polypose naso-sinusienne et biothérapie : revue des études de vraie vie
X. Dufour, Florent Carsuzaa
Revue française d'allergologie (2024) Vol. 64, pp. 103800-103800
Closed Access
Biologic Therapies across Nasal Polyp Subtypes
Kody G. Bolk, Sarah K. Wise
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 432-432
Open Access
Efectividad real de la terapia biológica en el tratamiento de pacientes con rinosinusitis crónica con poliposis nasosinusal
Cristina García-García, Ithzel María Villarreal, Adriana Pardo-Maza, et al.
Revista ORL (2024) Vol. 15, Iss. 2, pp. e31902-e31902
Open Access
Investigation and Characterization of the RAS/RAF/MEK/ERK Pathway and Other Signaling Pathways in Chronic Sinusitis with Nasal Polyps
Zhipu Niu, Jichao Sha, Dongdong Zhu, et al.
International Archives of Allergy and Immunology (2024), pp. 1-12
Closed Access
Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Effect of Treatment with Emphasis on Biological Therapy
Josje Janna Otten, Wytske J. Fokkens, Sietze Reitsma
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access
Upper and lower airway interactions in children
Fernando M. de Benedictis
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 24, Iss. 1, pp. 9-14
Closed Access | Times Cited: 1
Osteopontin as a Novel Biomarker in Distinguishing Chronic Rhinosinusitis with Nasal Polyp Endotypes and Predicting Disease Severity
Peiqiang Liu, Meng Liu, Yibin Sun, et al.
International Archives of Allergy and Immunology (2024), pp. 1-11
Closed Access
Page 1

Scroll to top